1. Home
  2. UP vs PYXS Comparison

UP vs PYXS Comparison

Compare UP & PYXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wheels Up Experience Inc.

UP

Wheels Up Experience Inc.

N/A

Current Price

$3.13

Market Cap

134.2M

ML Signal

N/A

Logo Pyxis Oncology Inc.

PYXS

Pyxis Oncology Inc.

N/A

Current Price

$1.81

Market Cap

141.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
UP
PYXS
Founded
2013
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Aerospace
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
134.2M
141.3M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
UP
PYXS
Price
$3.13
$1.81
Analyst Decision
Strong Buy
Analyst Count
0
9
Target Price
N/A
★ $8.88
AVG Volume (30 Days)
75.1K
★ 963.4K
Earning Date
11-13-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 14.29
3.03
EPS
N/A
★ N/A
Revenue
★ $736,495,000.00
$13,858,000.00
Revenue This Year
$193.34
N/A
Revenue Next Year
$12.65
$14,188.99
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.36
$1.03
52 Week High
$10.09
$5.55

Technical Indicators

Market Signals
Indicator
UP
PYXS
Relative Strength Index (RSI) 40.29 38.33
Support Level $0.47 $1.59
Resistance Level $4.01 $1.84
Average True Range (ATR) 0.22 0.13
MACD 0.01 0.05
Stochastic Oscillator 37.74 44.85

Price Performance

Historical Comparison
UP
PYXS

About UP Wheels Up Experience Inc.

Wheels Up Experience Inc is a provider of on-demand private aviation. The company offers a private aviation solution with a large and diverse aircraft fleet, delivered through a mix of charter solutions and its membership program that utilizes its controlled aircraft fleet and a network of safety-vetted charter operators. Through its partnership firm, it provides members and customers with an offering across private and premium commercial travel. It generates the majority of its revenue from member and customer flights through its membership program and charter solutions, as well as from membership fees and other activities and services, including group charter flights, cargo flights, and special missions. Geographically, the company generates maximum revenue from the United States.

About PYXS Pyxis Oncology Inc.

Pyxis Oncology Inc is a clinical-stage oncology company focused on developing therapies for patients with solid tumors, with an initial emphasis on head and neck squamous cell carcinoma. Its product candidate, micvotabart pelidotin (MICVO, formerly PYX-201), is an investigational antibody-drug conjugate that targets extradomain-B fibronectin (EDB+FN), a component of the tumor extracellular matrix that is expressed in tumors and minimally present in normal tissues. MICVO consists of a fully human monoclonal antibody linked to a microtubule inhibitor payload, designed to bind within the tumor microenvironment and release its payload to kill cancer cells directly, affect nearby cells through a bystander effect, and induce immunogenic cell death, supporting enhanced anti-tumor activity.

Share on Social Networks: